143 related articles for article (PubMed ID: 3892637)
1. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
Krauledat PB; Krapf FE; Manger B; Kalden JR
Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
3. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
4. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
Kilpatrick JM; Virella G
Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
[TBL] [Abstract][Full Text] [Related]
5. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
6. The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.
Morrow WJ; Williams DJ; Ferec C; Casburn-Budd R; Isenberg DA; Paice E; Snaith ML; Youinou P; Le Goff P
Ann Rheum Dis; 1983 Dec; 42(6):668-71. PubMed ID: 6606402
[TBL] [Abstract][Full Text] [Related]
7. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
[TBL] [Abstract][Full Text] [Related]
8. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera.
Krapf F; Renger D; Schedel I; Leiendecker K; Leyssens H; Deicher H
J Immunol Methods; 1982 Oct; 54(1):107-17. PubMed ID: 7142715
[No Abstract] [Full Text] [Related]
9. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
10. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.
Bourke BE; Moss IK; Maini RN
J Immunol Methods; 1982; 48(1):97-108. PubMed ID: 6799579
[TBL] [Abstract][Full Text] [Related]
12. [Circulating immune complexes and anti-IgG antibodies in rheumatoid disease. Value of C3d assay].
Duquesnoy B; Santoro F; Siame JL; Vanhille P; Raviart B; Wattre P; Lemaitre V; Hatron PY
Rev Med Interne; 1981; 2(1):11-6. PubMed ID: 6972076
[No Abstract] [Full Text] [Related]
13. Immune complexes and complement catabolism in ankylosing spondylitis.
Gabay R; Zubler RH; Nydegger UE; Lambert PH
Arthritis Rheum; 1977 May; 20(4):913-6. PubMed ID: 140691
[TBL] [Abstract][Full Text] [Related]
14. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
15. [Demonstration and differentiation of circulating immune complexes in chronic inflammatory rheumatic diseases using a semiautomated PEG-precipitation laser nephelometer test].
Geissler N; Kemper A; Krapf E; Renger D; Schedel I; Deicher H
Z Rheumatol; 1985; 44(2):57-63. PubMed ID: 4050141
[TBL] [Abstract][Full Text] [Related]
16. Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis.
Muso E; Sekita K; Doi T; Kuwahara T; Yoshida H; Tamura T; Kawai C; Hamashima Y
Clin Immunol Immunopathol; 1984 Sep; 32(3):351-8. PubMed ID: 6380844
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of a new nephelometric technique to measure complement activation.
Vergani D; Bevis L; Nasaruddin BA; Mieli-Vergani G; Tee DE
J Clin Pathol; 1983 Jul; 36(7):793-7. PubMed ID: 6602812
[TBL] [Abstract][Full Text] [Related]
18. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
19. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in ankylosing spondylitis.
Deicher H; Ebringer A; Hildebrand S; Kemper A; Zeidler H
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):122-7. PubMed ID: 6652392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
